NCT04068597 2025-12-18
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
CellCentric Ltd.
Phase 1/2 Recruiting
CellCentric Ltd.
Onward Therapeutics
M.D. Anderson Cancer Center
SCRI Development Innovations, LLC
Ipsen
AbbVie
European Myeloma Network B.V.
M.D. Anderson Cancer Center